

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.45241913 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.45241913 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.04126814 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.04126814 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.48863851 |
| 6 | exogenous drug catabolic process (GO:0042738) | 5.68599065 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.63391885 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.63391885 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.63391885 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.49027907 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.42792503 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.42718070 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.29765796 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.27616674 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.26283622 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.98718147 |
| 17 | protein carboxylation (GO:0018214) | 4.98718147 |
| 18 | urea metabolic process (GO:0019627) | 4.98171505 |
| 19 | urea cycle (GO:0000050) | 4.98171505 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.92196159 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 4.90058552 |
| 22 | cysteine metabolic process (GO:0006534) | 4.83604114 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 4.75429112 |
| 24 | regulation of fibrinolysis (GO:0051917) | 4.71933725 |
| 25 | aromatic amino acid family metabolic process (GO:0009072) | 4.70319271 |
| 26 | bile acid metabolic process (GO:0008206) | 4.69749977 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.64675876 |
| 28 | tyrosine metabolic process (GO:0006570) | 4.63643875 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.60729084 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.58516454 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.58035381 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.52206139 |
| 33 | lysine catabolic process (GO:0006554) | 4.51968369 |
| 34 | lysine metabolic process (GO:0006553) | 4.51968369 |
| 35 | acylglycerol homeostasis (GO:0055090) | 4.50707324 |
| 36 | triglyceride homeostasis (GO:0070328) | 4.50707324 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.43292487 |
| 38 | epoxygenase P450 pathway (GO:0019373) | 4.43087945 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.37899039 |
| 40 | cellular ketone body metabolic process (GO:0046950) | 4.31164320 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.31082214 |
| 42 | phospholipid efflux (GO:0033700) | 4.26724660 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.23794653 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.23001380 |
| 45 | bile acid and bile salt transport (GO:0015721) | 4.22787693 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.20561883 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.20561883 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.20561883 |
| 49 | S-adenosylmethionine metabolic process (GO:0046500) | 4.20554777 |
| 50 | regulation of complement activation (GO:0030449) | 4.19479485 |
| 51 | indolalkylamine metabolic process (GO:0006586) | 4.18475517 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.14339747 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.02746543 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.02746543 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 3.96767924 |
| 56 | cellular amino acid catabolic process (GO:0009063) | 3.93695057 |
| 57 | imidazole-containing compound metabolic process (GO:0052803) | 3.90346625 |
| 58 | coenzyme catabolic process (GO:0009109) | 3.90201195 |
| 59 | intestinal cholesterol absorption (GO:0030299) | 3.89863430 |
| 60 | cholesterol efflux (GO:0033344) | 3.86236393 |
| 61 | glycine metabolic process (GO:0006544) | 3.83690224 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 3.80824576 |
| 63 | amine catabolic process (GO:0009310) | 3.80824576 |
| 64 | regulation of cholesterol homeostasis (GO:2000188) | 3.78791495 |
| 65 | glutamate metabolic process (GO:0006536) | 3.74598699 |
| 66 | uronic acid metabolic process (GO:0006063) | 3.74256096 |
| 67 | glucuronate metabolic process (GO:0019585) | 3.74256096 |
| 68 | drug catabolic process (GO:0042737) | 3.74249172 |
| 69 | drug transmembrane transport (GO:0006855) | 3.74166657 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 3.72005464 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 3.71846558 |
| 72 | ketone body metabolic process (GO:1902224) | 3.71743724 |
| 73 | phospholipid homeostasis (GO:0055091) | 3.71302180 |
| 74 | omega-hydroxylase P450 pathway (GO:0097267) | 3.68518890 |
| 75 | plasma lipoprotein particle assembly (GO:0034377) | 3.68259023 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 3.66872813 |
| 77 | regulation of bile acid biosynthetic process (GO:0070857) | 3.63239701 |
| 78 | cellular glucuronidation (GO:0052695) | 3.57543597 |
| 79 | synapsis (GO:0007129) | 3.57379156 |
| 80 | oxidative demethylation (GO:0070989) | 3.56856173 |
| 81 | organic acid catabolic process (GO:0016054) | 3.53281981 |
| 82 | carboxylic acid catabolic process (GO:0046395) | 3.53281981 |
| 83 | short-chain fatty acid metabolic process (GO:0046459) | 3.49767298 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.49700719 |
| 85 | low-density lipoprotein particle remodeling (GO:0034374) | 3.48608803 |
| 86 | fatty acid beta-oxidation (GO:0006635) | 3.48539856 |
| 87 | lipoprotein metabolic process (GO:0042157) | 3.47662586 |
| 88 | fatty acid oxidation (GO:0019395) | 3.46421629 |
| 89 | valine metabolic process (GO:0006573) | 3.46038655 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.41700657 |
| 91 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.39533668 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.39533668 |
| 93 | lipid oxidation (GO:0034440) | 3.38632199 |
| 94 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.38233008 |
| 95 | monocarboxylic acid catabolic process (GO:0072329) | 3.38163516 |
| 96 | sterol homeostasis (GO:0055092) | 3.37094231 |
| 97 | 2-oxoglutarate metabolic process (GO:0006103) | 3.35053576 |
| 98 | positive regulation of lipid catabolic process (GO:0050996) | 3.34923925 |
| 99 | fucose catabolic process (GO:0019317) | 3.34224970 |
| 100 | L-fucose metabolic process (GO:0042354) | 3.34224970 |
| 101 | L-fucose catabolic process (GO:0042355) | 3.34224970 |
| 102 | fibrinolysis (GO:0042730) | 3.33879569 |
| 103 | urate metabolic process (GO:0046415) | 3.33452910 |
| 104 | fatty acid catabolic process (GO:0009062) | 3.32953212 |
| 105 | cofactor catabolic process (GO:0051187) | 3.32147885 |
| 106 | ethanol oxidation (GO:0006069) | 3.31760637 |
| 107 | plasma lipoprotein particle organization (GO:0071827) | 3.31255481 |
| 108 | serine family amino acid biosynthetic process (GO:0009070) | 3.30738922 |
| 109 | blood coagulation, intrinsic pathway (GO:0007597) | 3.30603360 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.30317600 |
| 111 | drug metabolic process (GO:0017144) | 3.29977367 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.28907111 |
| 113 | response to pheromone (GO:0019236) | 3.15198224 |
| 114 | heme transport (GO:0015886) | 3.09524051 |
| 115 | cellular response to ethanol (GO:0071361) | 3.05342615 |
| 116 | L-methionine salvage (GO:0071267) | 3.03802797 |
| 117 | L-methionine biosynthetic process (GO:0071265) | 3.03802797 |
| 118 | amino acid salvage (GO:0043102) | 3.03802797 |
| 119 | alkaloid metabolic process (GO:0009820) | 2.95545206 |
| 120 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.83087988 |
| 121 | piRNA metabolic process (GO:0034587) | 2.82737931 |
| 122 | organic cation transport (GO:0015695) | 2.82424387 |
| 123 | interkinetic nuclear migration (GO:0022027) | 2.79118026 |
| 124 | protein K11-linked deubiquitination (GO:0035871) | 2.78500446 |
| 125 | neural tube formation (GO:0001841) | 2.76683029 |
| 126 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.71688849 |
| 127 | ethanol metabolic process (GO:0006067) | 2.59366476 |
| 128 | rRNA catabolic process (GO:0016075) | 2.55388782 |
| 129 | methionine biosynthetic process (GO:0009086) | 2.54947370 |
| 130 | sodium-independent organic anion transport (GO:0043252) | 2.54318409 |
| 131 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.52244061 |
| 132 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.50464294 |
| 133 | flavonoid metabolic process (GO:0009812) | 2.50213066 |
| 134 | indole-containing compound metabolic process (GO:0042430) | 2.49111474 |
| 135 | drug transport (GO:0015893) | 2.45490290 |
| 136 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.44407566 |
| 137 | positive regulation of fatty acid transport (GO:2000193) | 2.42883120 |
| 138 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.40523058 |
| 139 | reciprocal DNA recombination (GO:0035825) | 2.40137106 |
| 140 | reciprocal meiotic recombination (GO:0007131) | 2.40137106 |
| 141 | regulation of protein polyubiquitination (GO:1902914) | 2.37366762 |
| 142 | regulation of memory T cell differentiation (GO:0043380) | 2.36552811 |
| 143 | negative regulation of protein activation cascade (GO:2000258) | 2.36159355 |
| 144 | protein localization to Golgi apparatus (GO:0034067) | 2.35338081 |
| 145 | establishment of protein localization to Golgi (GO:0072600) | 2.32944855 |
| 146 | dopamine transport (GO:0015872) | 2.32794119 |
| 147 | disruption of cells of other organism (GO:0044364) | 2.32766828 |
| 148 | killing of cells of other organism (GO:0031640) | 2.32766828 |
| 149 | detection of light stimulus involved in visual perception (GO:0050908) | 2.31842114 |
| 150 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.31842114 |
| 151 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.28613434 |
| 152 | phenylpropanoid metabolic process (GO:0009698) | 2.28268911 |
| 153 | C4-dicarboxylate transport (GO:0015740) | 2.28166518 |
| 154 | branched-chain amino acid catabolic process (GO:0009083) | 2.27988352 |
| 155 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.27268246 |
| 156 | xenobiotic metabolic process (GO:0006805) | 2.26842894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.79363576 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.69281054 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.33148041 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.21015364 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.92327149 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.82152334 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.31359938 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.97821412 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74643507 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.28916252 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.12363600 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.87359555 |
| 13 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.86150448 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.62264969 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.57242585 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 2.53379892 |
| 17 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.41844905 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.38372820 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.35179442 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.27527075 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18121880 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.14979625 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 2.07543894 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.01169565 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7172754 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95283063 |
| 27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95220471 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.94618051 |
| 29 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.94291287 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.93902740 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89544618 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.80681182 |
| 33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.78387865 |
| 34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.70937108 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.69726888 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65607014 |
| 37 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.55926749 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.55822458 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.55695471 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.54776232 |
| 41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.54127169 |
| 42 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.53563528 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51002384 |
| 44 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.50779983 |
| 45 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.50779983 |
| 46 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.48181384 |
| 47 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.48008125 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47618423 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47140841 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46283899 |
| 51 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.46095171 |
| 52 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.45855142 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.45329315 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43267646 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.42757901 |
| 56 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.41639370 |
| 57 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.40905216 |
| 58 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38930620 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.38099010 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34897957 |
| 61 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.33670299 |
| 62 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.33670299 |
| 63 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31190806 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.30575762 |
| 65 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.29138234 |
| 66 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.25560142 |
| 67 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25105885 |
| 68 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.24957836 |
| 69 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.23729729 |
| 70 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23323309 |
| 71 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.23233832 |
| 72 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.23158183 |
| 73 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.23158183 |
| 74 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.22719441 |
| 75 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.21910692 |
| 76 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20859085 |
| 77 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.20854709 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19363989 |
| 79 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18971792 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18343030 |
| 81 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17332842 |
| 82 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.16753496 |
| 83 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16668881 |
| 84 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14294598 |
| 85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13681376 |
| 86 | MYB_26560356_Chip-Seq_TH2_Human | 1.12379765 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12261546 |
| 88 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.11868042 |
| 89 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11141711 |
| 90 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.10866690 |
| 91 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10850760 |
| 92 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10693715 |
| 93 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09270700 |
| 94 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08765509 |
| 95 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08571867 |
| 96 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08470629 |
| 97 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08188624 |
| 98 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07686584 |
| 99 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.06885156 |
| 100 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06823210 |
| 101 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06752514 |
| 102 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.06502230 |
| 103 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06311719 |
| 104 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06274360 |
| 105 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.04093626 |
| 106 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03837405 |
| 107 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01781465 |
| 108 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95399537 |
| 109 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93610121 |
| 110 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.93184082 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89124626 |
| 112 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87715535 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86969968 |
| 114 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84331168 |
| 115 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.79194645 |
| 116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77273342 |
| 117 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73073491 |
| 118 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71906025 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71548025 |
| 120 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69834235 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69594088 |
| 122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.69057273 |
| 123 | GATA1_19941826_ChIP-Seq_K562_Human | 0.68842683 |
| 124 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.68035133 |
| 125 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.67151317 |
| 126 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65858889 |
| 127 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.65054471 |
| 128 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.63380207 |
| 129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62145782 |
| 130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62145782 |
| 131 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.61463222 |
| 132 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.61020102 |
| 133 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.60252581 |
| 134 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.59259460 |
| 135 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58733608 |
| 136 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.56722059 |
| 137 | CBP_21632823_ChIP-Seq_H3396_Human | 0.56666333 |
| 138 | GATA2_19941826_ChIP-Seq_K562_Human | 0.56087343 |
| 139 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.54134286 |
| 140 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53686044 |
| 141 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.52913442 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.52616500 |
| 143 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.52530342 |
| 144 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.51749478 |
| 145 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.51700460 |
| 146 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.51397287 |
| 147 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.51256554 |
| 148 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.50526421 |
| 149 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49972040 |
| 150 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.49343066 |
| 151 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49075526 |
| 152 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.48534770 |
| 153 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.47689022 |
| 154 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.47359052 |
| 155 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.47352221 |
| 156 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47222523 |
| 157 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45452073 |
| 158 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.44628740 |
| 159 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44561746 |
| 160 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.44237810 |
| 161 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.43343079 |
| 162 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.43219772 |
| 163 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.43160637 |
| 164 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.43061275 |
| 165 | GATA3_26560356_Chip-Seq_TH2_Human | 0.42769931 |
| 166 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.42290188 |
| 167 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42237112 |
| 168 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.41628882 |
| 169 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.41620942 |
| 170 | GATA3_26560356_Chip-Seq_TH1_Human | 0.41603276 |
| 171 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.40766009 |
| 172 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.40766009 |
| 173 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.40581331 |
| 174 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40451492 |
| 175 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.40430092 |
| 176 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.40400638 |
| 177 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40298394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.75430446 |
| 2 | MP0005360_urolithiasis | 6.76431511 |
| 3 | MP0005365_abnormal_bile_salt | 5.92881482 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.81767172 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.40691560 |
| 6 | MP0003252_abnormal_bile_duct | 4.07573287 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.90957512 |
| 8 | MP0003195_calcinosis | 3.39088184 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.32135819 |
| 10 | MP0004147_increased_porphyrin_level | 3.20780085 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.90199095 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.77231086 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.76633828 |
| 14 | MP0009840_abnormal_foam_cell | 2.72953499 |
| 15 | MP0005083_abnormal_biliary_tract | 2.69431208 |
| 16 | MP0005332_abnormal_amino_acid | 2.57303336 |
| 17 | MP0000609_abnormal_liver_physiology | 2.18206914 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.16978658 |
| 19 | MP0003868_abnormal_feces_composition | 2.11452115 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.00986312 |
| 21 | MP0002396_abnormal_hematopoietic_system | 1.98495807 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.95245041 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.94836642 |
| 24 | MP0008057_abnormal_DNA_replication | 1.87891405 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.71344303 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.70025710 |
| 27 | MP0005220_abnormal_exocrine_pancreas | 1.70016068 |
| 28 | MP0002254_reproductive_system_inflammat | 1.67529168 |
| 29 | MP0001873_stomach_inflammation | 1.63372162 |
| 30 | MP0000685_abnormal_immune_system | 1.63028154 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.61592798 |
| 32 | MP0004043_abnormal_pH_regulation | 1.59897450 |
| 33 | MP0001764_abnormal_homeostasis | 1.57780016 |
| 34 | MP0003283_abnormal_digestive_organ | 1.52694738 |
| 35 | MP0001800_abnormal_humoral_immune | 1.48548737 |
| 36 | MP0002078_abnormal_glucose_homeostasis | 1.44789058 |
| 37 | MP0001944_abnormal_pancreas_morphology | 1.40365640 |
| 38 | MP0005671_abnormal_response_to | 1.36034506 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35637328 |
| 40 | MP0002693_abnormal_pancreas_physiology | 1.33795410 |
| 41 | MP0005551_abnormal_eye_electrophysiolog | 1.29804055 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.29604344 |
| 43 | MP0009697_abnormal_copulation | 1.29037037 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.25809030 |
| 45 | MP0009785_altered_susceptibility_to | 1.24095568 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 1.20814888 |
| 47 | MP0005408_hypopigmentation | 1.18280161 |
| 48 | MP0008872_abnormal_physiological_respon | 1.17139360 |
| 49 | MP0000598_abnormal_liver_morphology | 1.16951254 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.16919610 |
| 51 | MP0002876_abnormal_thyroid_physiology | 1.16873576 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.15936481 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.15759417 |
| 54 | MP0000372_irregular_coat_pigmentation | 1.15753337 |
| 55 | MP0004142_abnormal_muscle_tone | 1.12557321 |
| 56 | MP0009780_abnormal_chondrocyte_physiolo | 1.12481897 |
| 57 | MP0003186_abnormal_redox_activity | 1.12043428 |
| 58 | MP0008058_abnormal_DNA_repair | 1.11881108 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.09787182 |
| 60 | MP0002723_abnormal_immune_serum | 1.09582764 |
| 61 | MP0002009_preneoplasia | 1.08854470 |
| 62 | MP0003718_maternal_effect | 1.05132886 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.05130340 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.05051665 |
| 65 | MP0005310_abnormal_salivary_gland | 1.04566356 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.03602440 |
| 67 | MP0002928_abnormal_bile_duct | 1.01282820 |
| 68 | MP0005000_abnormal_immune_tolerance | 1.00725289 |
| 69 | MP0005535_abnormal_body_temperature | 0.97466422 |
| 70 | MP0005379_endocrine/exocrine_gland_phen | 0.97427299 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.97404410 |
| 72 | MP0005670_abnormal_white_adipose | 0.96992885 |
| 73 | MP0001756_abnormal_urination | 0.96566011 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.96124951 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 0.93302569 |
| 76 | MP0005387_immune_system_phenotype | 0.93199145 |
| 77 | MP0001790_abnormal_immune_system | 0.93199145 |
| 78 | MP0005410_abnormal_fertilization | 0.93191250 |
| 79 | MP0005451_abnormal_body_composition | 0.92489362 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 0.91371495 |
| 81 | MP0005645_abnormal_hypothalamus_physiol | 0.91248834 |
| 82 | MP0002452_abnormal_antigen_presenting | 0.90842561 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.89895729 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.89568838 |
| 85 | MP0001919_abnormal_reproductive_system | 0.89378397 |
| 86 | MP0000427_abnormal_hair_cycle | 0.89304452 |
| 87 | MP0002166_altered_tumor_susceptibility | 0.89024204 |
| 88 | MP0008995_early_reproductive_senescence | 0.88519399 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.88332404 |
| 90 | MP0002420_abnormal_adaptive_immunity | 0.87368337 |
| 91 | MP0003943_abnormal_hepatobiliary_system | 0.86862156 |
| 92 | MP0001929_abnormal_gametogenesis | 0.86775977 |
| 93 | MP0001819_abnormal_immune_cell | 0.86507454 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.85392871 |
| 95 | MP0002398_abnormal_bone_marrow | 0.85175774 |
| 96 | MP0009763_increased_sensitivity_to | 0.84770339 |
| 97 | MP0002006_tumorigenesis | 0.84216280 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 0.82796410 |
| 99 | MP0008469_abnormal_protein_level | 0.81982309 |
| 100 | MP0002971_abnormal_brown_adipose | 0.81844349 |
| 101 | MP0000716_abnormal_immune_system | 0.80995050 |
| 102 | MP0003300_gastrointestinal_ulcer | 0.80935242 |
| 103 | MP0005025_abnormal_response_to | 0.80601565 |
| 104 | MP0005334_abnormal_fat_pad | 0.80220896 |
| 105 | MP0005647_abnormal_sex_gland | 0.79808289 |
| 106 | MP0002102_abnormal_ear_morphology | 0.79618464 |
| 107 | MP0005397_hematopoietic_system_phenotyp | 0.79595423 |
| 108 | MP0001545_abnormal_hematopoietic_system | 0.79595423 |
| 109 | MP0004885_abnormal_endolymph | 0.79165165 |
| 110 | MP0000604_amyloidosis | 0.78949001 |
| 111 | MP0009764_decreased_sensitivity_to | 0.78812220 |
| 112 | MP0003953_abnormal_hormone_level | 0.77295406 |
| 113 | MP0005448_abnormal_energy_balance | 0.76690580 |
| 114 | MP0001661_extended_life_span | 0.75486527 |
| 115 | MP0003646_muscle_fatigue | 0.72127369 |
| 116 | MP0002419_abnormal_innate_immunity | 0.72086844 |
| 117 | MP0002909_abnormal_adrenal_gland | 0.71120188 |
| 118 | MP0002405_respiratory_system_inflammati | 0.70742361 |
| 119 | MP0006082_CNS_inflammation | 0.70527783 |
| 120 | MP0000013_abnormal_adipose_tissue | 0.70177317 |
| 121 | MP0003787_abnormal_imprinting | 0.70030427 |
| 122 | MP0005389_reproductive_system_phenotype | 0.69686316 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.69154198 |
| 124 | MP0001501_abnormal_sleep_pattern | 0.69072245 |
| 125 | MP0001188_hyperpigmentation | 0.68536274 |
| 126 | MP0002132_abnormal_respiratory_system | 0.68373955 |
| 127 | MP0005376_homeostasis/metabolism_phenot | 0.67441905 |
| 128 | MP0010386_abnormal_urinary_bladder | 0.67124641 |
| 129 | MP0000639_abnormal_adrenal_gland | 0.63692870 |
| 130 | MP0004130_abnormal_muscle_cell | 0.63118061 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.62829583 |
| 132 | MP0005266_abnormal_metabolism | 0.61981381 |
| 133 | MP0005666_abnormal_adipose_tissue | 0.61153893 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.56296771 |
| 135 | MP0002136_abnormal_kidney_physiology | 0.54253957 |
| 136 | MP0003011_delayed_dark_adaptation | 0.53036730 |
| 137 | MP0004185_abnormal_adipocyte_glucose | 0.51717353 |
| 138 | MP0010368_abnormal_lymphatic_system | 0.49066050 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.48367387 |
| 140 | MP0009672_abnormal_birth_weight | 0.47808010 |
| 141 | MP0003183_abnormal_peptide_metabolism | 0.45155130 |
| 142 | MP0003959_abnormal_lean_body | 0.44930728 |
| 143 | MP0002970_abnormal_white_adipose | 0.43240754 |
| 144 | MP0003724_increased_susceptibility_to | 0.42066178 |
| 145 | MP0002896_abnormal_bone_mineralization | 0.40972561 |
| 146 | MP0006035_abnormal_mitochondrial_morpho | 0.40835703 |
| 147 | MP0005395_other_phenotype | 0.40744091 |
| 148 | MP0008961_abnormal_basal_metabolism | 0.39534059 |
| 149 | MP0000538_abnormal_urinary_bladder | 0.39470008 |
| 150 | MP0005464_abnormal_platelet_physiology | 0.38611057 |
| 151 | MP0003890_abnormal_embryonic-extraembry | 0.38325121 |
| 152 | MP0003638_abnormal_response/metabolism_ | 0.37631378 |
| 153 | MP0005375_adipose_tissue_phenotype | 0.37583749 |
| 154 | MP0000613_abnormal_salivary_gland | 0.37371371 |
| 155 | MP0002168_other_aberrant_phenotype | 0.36091092 |
| 156 | MP0005646_abnormal_pituitary_gland | 0.35335331 |
| 157 | MP0001881_abnormal_mammary_gland | 0.35132700 |
| 158 | MP0005248_abnormal_Harderian_gland | 0.33672513 |
| 159 | MP0000003_abnormal_adipose_tissue | 0.33142991 |
| 160 | MP0001845_abnormal_inflammatory_respons | 0.32944266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.43771960 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.87656306 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.98762095 |
| 4 | Hypoglycemic coma (HP:0001325) | 5.90302943 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.84222120 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.81171161 |
| 7 | Xanthomatosis (HP:0000991) | 5.47739637 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.28224634 |
| 9 | Hypoglycemic seizures (HP:0002173) | 4.83396333 |
| 10 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.60912496 |
| 11 | Ketosis (HP:0001946) | 4.60689897 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.34095866 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.33435381 |
| 14 | Abnormality of the intrinsic pathway (HP:0010989) | 4.30876964 |
| 15 | Ketoacidosis (HP:0001993) | 4.28332689 |
| 16 | Complement deficiency (HP:0004431) | 4.16689976 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 4.16050630 |
| 18 | Fat malabsorption (HP:0002630) | 4.08344040 |
| 19 | Epidermoid cyst (HP:0200040) | 4.05206979 |
| 20 | Hyperglycinemia (HP:0002154) | 3.98766888 |
| 21 | Joint hemorrhage (HP:0005261) | 3.97239369 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.97093695 |
| 23 | Hyperammonemia (HP:0001987) | 3.88891980 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.86833310 |
| 25 | Symptomatic seizures (HP:0011145) | 3.82024380 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.77001264 |
| 27 | Hyperglycinuria (HP:0003108) | 3.73975556 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.69122515 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.60633853 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.58735471 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.52131276 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.52131276 |
| 33 | Hyperglycemia (HP:0003074) | 3.51015316 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 3.46011482 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.39311542 |
| 36 | Generalized aminoaciduria (HP:0002909) | 3.39113149 |
| 37 | Late onset (HP:0003584) | 3.36064904 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32905297 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.28442510 |
| 40 | Abnormality of the renal cortex (HP:0011035) | 3.09450096 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 3.04658765 |
| 42 | Abnormality of complement system (HP:0005339) | 2.98592990 |
| 43 | Skin nodule (HP:0200036) | 2.97286034 |
| 44 | Chronic hepatic failure (HP:0100626) | 2.96879607 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.96507685 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.95980979 |
| 47 | Pancreatic cysts (HP:0001737) | 2.92211617 |
| 48 | Gout (HP:0001997) | 2.90556486 |
| 49 | Steatorrhea (HP:0002570) | 2.88389947 |
| 50 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.85866830 |
| 51 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.85866830 |
| 52 | Abnormality of B cell number (HP:0010975) | 2.81647846 |
| 53 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.80205527 |
| 54 | Myocardial infarction (HP:0001658) | 2.72937389 |
| 55 | Panhypogammaglobulinemia (HP:0003139) | 2.71669371 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64619601 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 2.64619601 |
| 58 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.64368527 |
| 59 | Stomach cancer (HP:0012126) | 2.63831221 |
| 60 | Hepatocellular carcinoma (HP:0001402) | 2.63422176 |
| 61 | Abnormality of serum amino acid levels (HP:0003112) | 2.63263834 |
| 62 | Metabolic acidosis (HP:0001942) | 2.62919051 |
| 63 | Attenuation of retinal blood vessels (HP:0007843) | 2.62420101 |
| 64 | Delayed CNS myelination (HP:0002188) | 2.58510603 |
| 65 | Medial flaring of the eyebrow (HP:0010747) | 2.58287273 |
| 66 | Thyroiditis (HP:0100646) | 2.56138883 |
| 67 | Abnormal biliary tract physiology (HP:0012439) | 2.54595779 |
| 68 | Bile duct proliferation (HP:0001408) | 2.54595779 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.53428694 |
| 70 | B lymphocytopenia (HP:0010976) | 2.47638303 |
| 71 | Limb hypertonia (HP:0002509) | 2.47567978 |
| 72 | Chronic sinusitis (HP:0011109) | 2.46398409 |
| 73 | Fair hair (HP:0002286) | 2.45732943 |
| 74 | Pancreatic fibrosis (HP:0100732) | 2.43359495 |
| 75 | Stomatitis (HP:0010280) | 2.39660402 |
| 76 | * Irritability (HP:0000737) | 2.38381251 |
| 77 | Hypochromic microcytic anemia (HP:0004840) | 2.36055693 |
| 78 | Abnormal gallbladder morphology (HP:0012437) | 2.35068888 |
| 79 | Lethargy (HP:0001254) | 2.34246685 |
| 80 | Enlarged kidneys (HP:0000105) | 2.33016979 |
| 81 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.32329476 |
| 82 | Absent/shortened dynein arms (HP:0200106) | 2.32329476 |
| 83 | Severe combined immunodeficiency (HP:0004430) | 2.30812681 |
| 84 | Spontaneous abortion (HP:0005268) | 2.29588956 |
| 85 | 3-Methylglutaconic aciduria (HP:0003535) | 2.28508550 |
| 86 | Acanthocytosis (HP:0001927) | 2.26570583 |
| 87 | Hypothermia (HP:0002045) | 2.26279408 |
| 88 | Molar tooth sign on MRI (HP:0002419) | 2.23641629 |
| 89 | Abnormality of midbrain morphology (HP:0002418) | 2.23641629 |
| 90 | Congenital stationary night blindness (HP:0007642) | 2.23357903 |
| 91 | Mitral stenosis (HP:0001718) | 2.22192944 |
| 92 | Nephronophthisis (HP:0000090) | 2.21389750 |
| 93 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.20993297 |
| 94 | Pancreatitis (HP:0001733) | 2.18213327 |
| 95 | Renal cortical cysts (HP:0000803) | 2.16993454 |
| 96 | True hermaphroditism (HP:0010459) | 2.14941591 |
| 97 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.13825048 |
| 98 | Abnormality of alanine metabolism (HP:0010916) | 2.13825048 |
| 99 | Hyperalaninemia (HP:0003348) | 2.13825048 |
| 100 | Abnormality of urine glucose concentration (HP:0011016) | 2.13214795 |
| 101 | Glycosuria (HP:0003076) | 2.13214795 |
| 102 | Abnormality of T cell number (HP:0011839) | 2.12971874 |
| 103 | Proximal tubulopathy (HP:0000114) | 2.12271949 |
| 104 | Congenital primary aphakia (HP:0007707) | 2.11230737 |
| 105 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.10571289 |
| 106 | Abolished electroretinogram (ERG) (HP:0000550) | 2.10258151 |
| 107 | Elevated alkaline phosphatase (HP:0003155) | 2.08836284 |
| 108 | Insulin resistance (HP:0000855) | 2.08658269 |
| 109 | Brushfield spots (HP:0001088) | 2.06939556 |
| 110 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.06151539 |
| 111 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.06151539 |
| 112 | Vascular calcification (HP:0004934) | 2.04585069 |
| 113 | Nephrogenic diabetes insipidus (HP:0009806) | 2.04071228 |
| 114 | T lymphocytopenia (HP:0005403) | 2.01963003 |
| 115 | Alkalosis (HP:0001948) | 2.01658032 |
| 116 | Abnormality of proline metabolism (HP:0010907) | 2.01185304 |
| 117 | Hydroxyprolinuria (HP:0003080) | 2.01185304 |
| 118 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.00682659 |
| 119 | Abnormality of the renal medulla (HP:0100957) | 1.99966181 |
| 120 | Rickets (HP:0002748) | 1.99896445 |
| 121 | Acute hepatic failure (HP:0006554) | 1.99894525 |
| 122 | Cerebral edema (HP:0002181) | 1.97141739 |
| 123 | Decreased central vision (HP:0007663) | 1.96877158 |
| 124 | Gait imbalance (HP:0002141) | 1.96859472 |
| 125 | Malnutrition (HP:0004395) | 1.96501680 |
| 126 | Progressive inability to walk (HP:0002505) | 1.93886767 |
| 127 | Abnormal ciliary motility (HP:0012262) | 1.92917916 |
| 128 | Abnormality of macular pigmentation (HP:0008002) | 1.92654937 |
| 129 | Protuberant abdomen (HP:0001538) | 1.91897273 |
| 130 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.91475368 |
| 131 | Systemic lupus erythematosus (HP:0002725) | 1.90064102 |
| 132 | Abnormality of the gallbladder (HP:0005264) | 1.89680426 |
| 133 | Abnormality of T cells (HP:0002843) | 1.89227236 |
| 134 | Abnormality of eosinophils (HP:0001879) | 1.89185969 |
| 135 | Cholelithiasis (HP:0001081) | 1.88953810 |
| 136 | Vomiting (HP:0002013) | 1.88870866 |
| 137 | Sensorimotor neuropathy (HP:0007141) | 1.88851444 |
| 138 | IgG deficiency (HP:0004315) | 1.88637065 |
| 139 | Menorrhagia (HP:0000132) | 1.88548137 |
| 140 | Central scotoma (HP:0000603) | 1.88329647 |
| 141 | Constricted visual fields (HP:0001133) | 1.88293791 |
| 142 | Encephalitis (HP:0002383) | 1.88174968 |
| 143 | Esophageal varix (HP:0002040) | 1.87586786 |
| 144 | Spastic diplegia (HP:0001264) | 1.87278688 |
| 145 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.86118370 |
| 146 | Alveolar cell carcinoma (HP:0006519) | 1.85346284 |
| 147 | Gingival bleeding (HP:0000225) | 1.85232305 |
| 148 | Death in childhood (HP:0003819) | 1.84721643 |
| 149 | Keratoconjunctivitis (HP:0001096) | 1.82824399 |
| 150 | Poikilocytosis (HP:0004447) | 1.82705713 |
| 151 | Increased purine levels (HP:0004368) | 1.81917198 |
| 152 | Hyperuricemia (HP:0002149) | 1.81917198 |
| 153 | Glomerulonephritis (HP:0000099) | 1.81737962 |
| 154 | Optic neuritis (HP:0100653) | 1.81455396 |
| 155 | Retrobulbar optic neuritis (HP:0100654) | 1.81455396 |
| 156 | Poor coordination (HP:0002370) | 1.80707429 |
| 157 | Hypoproteinemia (HP:0003075) | 1.80009575 |
| 158 | Chronic otitis media (HP:0000389) | 1.79715726 |
| 159 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.79707005 |
| 160 | Recurrent cutaneous fungal infections (HP:0011370) | 1.79707005 |
| 161 | Abnormality of vitamin B metabolism (HP:0004340) | 1.79695914 |
| 162 | Hypophosphatemia (HP:0002148) | 1.79615771 |
| 163 | Abnormality of T cell physiology (HP:0011840) | 1.77944024 |
| 164 | Hyperventilation (HP:0002883) | 1.77453287 |
| 165 | Abnormality of vitamin metabolism (HP:0100508) | 1.77431123 |
| 166 | Generalized hypopigmentation of hair (HP:0011358) | 1.76387065 |
| 167 | Abnormality of chromosome stability (HP:0003220) | 1.75443569 |
| 168 | Myositis (HP:0100614) | 1.74400342 |
| 169 | Combined immunodeficiency (HP:0005387) | 1.73910771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 7.24897051 |
| 2 | BCKDK | 4.66376691 |
| 3 | TAOK3 | 4.00933437 |
| 4 | ACVR1B | 3.43703822 |
| 5 | ERN1 | 3.43671753 |
| 6 | SIK1 | 3.16341756 |
| 7 | ZAK | 3.05972890 |
| 8 | FGFR4 | 3.03551266 |
| 9 | FLT3 | 2.91864592 |
| 10 | MAPK15 | 2.60321686 |
| 11 | FRK | 2.50971582 |
| 12 | PASK | 2.40787039 |
| 13 | MAP4K2 | 2.33730866 |
| 14 | TRIB3 | 2.24320250 |
| 15 | CAMKK2 | 2.13073049 |
| 16 | MAP3K3 | 1.97088135 |
| 17 | BMPR1B | 1.96237626 |
| 18 | ADRBK2 | 1.91971408 |
| 19 | TXK | 1.88084866 |
| 20 | IRAK3 | 1.79900755 |
| 21 | PTK6 | 1.72177653 |
| 22 | PIK3CG | 1.58933630 |
| 23 | BRSK2 | 1.53482263 |
| 24 | HIPK2 | 1.51974575 |
| 25 | ERBB4 | 1.49653871 |
| 26 | PKN2 | 1.48108065 |
| 27 | MAP3K4 | 1.45187518 |
| 28 | MAP3K14 | 1.41266417 |
| 29 | TYK2 | 1.40979180 |
| 30 | SGK2 | 1.40222394 |
| 31 | EPHA3 | 1.37644719 |
| 32 | STK39 | 1.36811529 |
| 33 | MST1R | 1.35902909 |
| 34 | AKT3 | 1.33544446 |
| 35 | MAPK13 | 1.30976615 |
| 36 | DYRK3 | 1.30861696 |
| 37 | TEC | 1.30547772 |
| 38 | MAP3K2 | 1.29988798 |
| 39 | STK38L | 1.27792103 |
| 40 | TAF1 | 1.26336496 |
| 41 | PLK4 | 1.25905321 |
| 42 | MAPK11 | 1.25202352 |
| 43 | JAK2 | 1.23905683 |
| 44 | NEK9 | 1.22857464 |
| 45 | WNK4 | 1.22416634 |
| 46 | SGK3 | 1.18935057 |
| 47 | MKNK2 | 1.16024475 |
| 48 | PRKAA2 | 1.15838330 |
| 49 | MAP2K3 | 1.14919769 |
| 50 | OXSR1 | 1.14368426 |
| 51 | SYK | 1.11701058 |
| 52 | MET | 1.11227598 |
| 53 | LATS1 | 1.09858390 |
| 54 | JAK1 | 1.05772477 |
| 55 | WNK3 | 1.03048188 |
| 56 | MKNK1 | 1.02824755 |
| 57 | BMPR2 | 1.02479194 |
| 58 | PIK3CA | 1.02007691 |
| 59 | MAP4K1 | 1.01993919 |
| 60 | BCR | 1.01871705 |
| 61 | SGK223 | 0.97462605 |
| 62 | SGK494 | 0.97462605 |
| 63 | EIF2AK3 | 0.95682868 |
| 64 | JAK3 | 0.94005264 |
| 65 | TRPM7 | 0.90801269 |
| 66 | MAP2K4 | 0.90774441 |
| 67 | DYRK1B | 0.89464554 |
| 68 | TGFBR1 | 0.89192346 |
| 69 | MAPKAPK3 | 0.86583948 |
| 70 | ERBB3 | 0.85185976 |
| 71 | PRKCH | 0.82719566 |
| 72 | TBK1 | 0.82207408 |
| 73 | PDK2 | 0.81569199 |
| 74 | TLK1 | 0.80132951 |
| 75 | IRAK1 | 0.76618986 |
| 76 | DAPK2 | 0.76438694 |
| 77 | PTK2 | 0.75157401 |
| 78 | MAP2K7 | 0.74903036 |
| 79 | GSK3A | 0.74188372 |
| 80 | LCK | 0.73011015 |
| 81 | MST4 | 0.71817849 |
| 82 | PRKAA1 | 0.71555378 |
| 83 | PRKD3 | 0.71483986 |
| 84 | MATK | 0.69979516 |
| 85 | CHUK | 0.68306437 |
| 86 | MARK3 | 0.66585182 |
| 87 | CSNK1G1 | 0.66041774 |
| 88 | SCYL2 | 0.63425024 |
| 89 | PRKACG | 0.62912168 |
| 90 | WEE1 | 0.62604582 |
| 91 | MAPKAPK5 | 0.62211323 |
| 92 | CAMK1D | 0.62199444 |
| 93 | BTK | 0.61997232 |
| 94 | VRK1 | 0.61934796 |
| 95 | PRKD2 | 0.61552625 |
| 96 | MAP3K1 | 0.61454959 |
| 97 | RET | 0.61428220 |
| 98 | KIT | 0.59690810 |
| 99 | MAP2K6 | 0.59563149 |
| 100 | LYN | 0.58558373 |
| 101 | PIM1 | 0.57678890 |
| 102 | PRKCE | 0.56009618 |
| 103 | NLK | 0.55656362 |
| 104 | GRK6 | 0.55540913 |
| 105 | EPHB1 | 0.54936290 |
| 106 | CSNK1G2 | 0.53586850 |
| 107 | PDGFRA | 0.53506829 |
| 108 | FGFR3 | 0.53263363 |
| 109 | GRK7 | 0.50661317 |
| 110 | MAP3K6 | 0.50252376 |
| 111 | CSNK1G3 | 0.48659628 |
| 112 | CSK | 0.48498115 |
| 113 | TNIK | 0.48211448 |
| 114 | ITK | 0.47599850 |
| 115 | STK3 | 0.47286385 |
| 116 | TRIM28 | 0.46408008 |
| 117 | MAP2K2 | 0.46307765 |
| 118 | MAP3K12 | 0.45769369 |
| 119 | HCK | 0.44283817 |
| 120 | GRK1 | 0.41564061 |
| 121 | MTOR | 0.41457659 |
| 122 | CSNK1A1L | 0.40713819 |
| 123 | IGF1R | 0.40125197 |
| 124 | CSNK1D | 0.37209859 |
| 125 | MAP3K10 | 0.36626662 |
| 126 | NUAK1 | 0.36382120 |
| 127 | ABL2 | 0.35621339 |
| 128 | BLK | 0.35461695 |
| 129 | EIF2AK2 | 0.34846448 |
| 130 | OBSCN | 0.32921732 |
| 131 | ADRBK1 | 0.32756007 |
| 132 | PRKCZ | 0.32720661 |
| 133 | RPS6KB1 | 0.32555706 |
| 134 | CAMKK1 | 0.32291710 |
| 135 | PLK2 | 0.32202742 |
| 136 | CDK6 | 0.31774421 |
| 137 | MAP3K7 | 0.31755802 |
| 138 | PAK3 | 0.31634856 |
| 139 | IRAK2 | 0.31533904 |
| 140 | NTRK1 | 0.29777458 |
| 141 | PDPK1 | 0.29500407 |
| 142 | ZAP70 | 0.28190454 |
| 143 | PINK1 | 0.28004471 |
| 144 | KDR | 0.27330032 |
| 145 | MAP2K1 | 0.27219575 |
| 146 | FER | 0.26481774 |
| 147 | PDK4 | 0.26050245 |
| 148 | PDK3 | 0.26050245 |
| 149 | IKBKE | 0.26037496 |
| 150 | FGFR2 | 0.25623367 |
| 151 | PRKCQ | 0.25605775 |
| 152 | MAPK3 | 0.25553176 |
| 153 | ERBB2 | 0.24890074 |
| 154 | CDC42BPA | 0.23785515 |
| 155 | BRD4 | 0.22508689 |
| 156 | BRAF | 0.21708795 |
| 157 | EGFR | 0.21413119 |
| 158 | IRAK4 | 0.20859539 |
| 159 | IKBKB | 0.19624679 |
| 160 | CAMK2G | 0.18228010 |
| 161 | CSF1R | 0.17785935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.12622029 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.45380974 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.34333555 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10325418 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97392737 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.89652913 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.63892490 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.58038635 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50334357 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.48490582 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.36429490 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.35916590 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31357525 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23758050 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.19225960 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.14969960 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.04947864 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93916873 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91290641 |
| 20 | * Selenocompound metabolism_Homo sapiens_hsa00450 | 1.90493928 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.87215830 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85888755 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84249803 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80647650 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77036103 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69556207 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.68274766 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60570677 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.59902293 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58723784 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57899434 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.57837150 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54832421 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.53713689 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50331434 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.49532586 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49009956 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47258074 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.47140431 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.44040696 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42761640 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42552498 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42082916 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.41222003 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37119672 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.36170666 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36032665 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.34637129 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29869312 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29332342 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27087400 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26909057 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26112092 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24741888 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.19856580 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.17962845 |
| 57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.15158903 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14527034 |
| 59 | Protein export_Homo sapiens_hsa03060 | 1.06077444 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01662065 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.99617412 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99122946 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97559897 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 0.91280707 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89399846 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87191100 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.86734355 |
| 68 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86088834 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84941662 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84876995 |
| 71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83359441 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82358938 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80690481 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80400447 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78888401 |
| 76 | Basal transcription factors_Homo sapiens_hsa03022 | 0.78343323 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76976262 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74297739 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.72782352 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71666166 |
| 81 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67451014 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67195035 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65941812 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64339887 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64144647 |
| 86 | RNA degradation_Homo sapiens_hsa03018 | 0.63968180 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63705725 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61242877 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60783492 |
| 90 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55037142 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.54221887 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50562229 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49442777 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47381282 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46952137 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46605305 |
| 97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45973067 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45023930 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44648784 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42832323 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42092846 |
| 102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39615517 |
| 103 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39317461 |
| 104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38340580 |
| 105 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38116821 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36606590 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36458737 |
| 108 | Measles_Homo sapiens_hsa05162 | 0.36338413 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33547695 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31834471 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.31117209 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28412937 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28111396 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27825793 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27284984 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | 0.26776740 |
| 117 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.25597821 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.25512164 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23279083 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23081326 |
| 121 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19854196 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.19483351 |
| 123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19029708 |
| 124 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.18310090 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17789161 |
| 126 | Insulin secretion_Homo sapiens_hsa04911 | 0.15997978 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13560537 |
| 128 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11250707 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.07865760 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.07701983 |
| 131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.04710771 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.04527600 |
| 133 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.01474239 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0959727 |
| 135 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0935095 |
| 136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0880978 |
| 137 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0874370 |
| 138 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.0812495 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0545864 |
| 140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0387708 |
| 141 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0161954 |

